• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Matthew F. Covington, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
0 out of 5 Patient Rating

Languages Spoken: English

Dr. Covington is an expert in cancer imaging, with a specific career focus on improving early detection and accurate staging of breast cancer. Dr. Covington is a dual-subspecialist in breast imaging and nuclear radiology. Prior to joining the University of Utah, Dr. Covington completed a Breast and PET oncologic imaging fellowship at the Mayo Clinic in Arizona and thereafter joined the radiology faculty at the Mallinckrodt Institute of Radiology at the Washington University in St. Louis. In 2019, Dr. Covington joined the faculty at the University of Utah Department of Medical Imaging and the Huntsman Cancer Institute Center for Quantitative Cancer Imaging with a joint clinical and research appointment.

Dr. Covington has been named among the “Ones to Watch” by the Society of Nuclear Medicine and Molecular Imaging and has been awarded a prestigious 5 For the Fight fellowship for his work in molecular imaging of breast cancer. Dr. Covington is a principal investigator on a clinical trial evaluating 18F-Fluoroestradiol (FES) PET/CT imaging for individuals with invasive lobular carcinoma. Dr. Covington is also a principal investigator and collaborator on several other research studies at the Huntsman Cancer Institute, including work with CT-based body composition analysis for colon and renal cancers, circulating tumor DNA analysis, and evaluation of other novel and emerging PET imaging tracers to include FFNP-PET. Dr. Covington has unique experience with new and emerging breast imaging technologies that have led to multiple presentations and peer-reviewed publications on technologies such as contrast-enhanced mammography and molecular breast imaging.

Specialties

  • Mammography
  • Nuclear Medicine

Board Certification and Academic Information

Academic Departments Radiology and Imaging Sciences - Assistant Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Radiology
American Board of Radiology (Nuclear Radiology)

Dr. Covington is an expert in cancer imaging, with a specific career focus on improving early detection and accurate staging of breast cancer. Dr. Covington is a dual-subspecialist in breast imaging and nuclear radiology. Prior to joining the University of Utah, Dr. Covington completed a Breast and PET oncologic imaging fellowship at the Mayo Clinic in Arizona and thereafter joined the radiology faculty at the Mallinckrodt Institute of Radiology at the Washington University in St. Louis. In 2019, Dr. Covington joined the faculty at the University of Utah Department of Medical Imaging and the Huntsman Cancer Institute Center for Quantitative Cancer Imaging with a joint clinical and research appointment.

Dr. Covington has been named among the “Ones to Watch” by the Society of Nuclear Medicine and Molecular Imaging and has been awarded a prestigious 5 For the Fight fellowship for his work in molecular imaging of breast cancer. Dr. Covington is a principal investigator on a clinical trial evaluating 18F-Fluoroestradiol (FES) PET/CT imaging for individuals with invasive lobular carcinoma. Dr. Covington is also a principal investigator and collaborator on several other research studies at the Huntsman Cancer Institute, including work with CT-based body composition analysis for colon and renal cancers, circulating tumor DNA analysis, and evaluation of other novel and emerging PET imaging tracers to include FFNP-PET. Dr. Covington has unique experience with new and emerging breast imaging technologies that have led to multiple presentations and peer-reviewed publications on technologies such as contrast-enhanced mammography and molecular breast imaging.

Academic Locations

Board Certification and Academic Information

Academic Departments Radiology and Imaging Sciences - Assistant Professor
Academic Divisions Clinical Radiology
Board Certification American Board of Radiology
American Board of Radiology (Nuclear Radiology)

Education History

Fellowship Mayo Clinic
Women’s Imaging
Fellow, 2017
Fellowship University of Arizona College of Medicine – Tucson
Nuclear Radiology
Fellow, 2016
Residency University of Arizona College of Medicine – Tucson
Diagnostic Radiology
Resident, 2015
Internship Scripps Mercy Hospital

Transitional Internship, 2012
Professional Medical University of Utah School of Medicine
Medicine
M.D., 2011
Other Training National Institutes of Health
Intramural Research Training Award Program
Postbaccalaureate Studies, 2007
Undergraduate Brigham Young University
Psychology
B.S., 2006

Selected Publications - Journal Articles

Journal Article

  1. Poplack SP, Young CA, Hagemann IS, Luo J, Herman CR, Wiele K, Li S, Zeng Y, Covington MF, Zhu Q (2021). Prospective assessment of adjunctive ultrasound-guided diffuse optical tomography in women undergoing breast biopsy: Impact on BI-RADS assessments. Eur J Radiol, 145, 110029.
  2. Zhu Q, Ademuyiwa FO, Young C, Appleton C, Covington MF, Ma C, Sanati S, Hagemann IS, Mostafa A, Uddin KMS, Grigsby I, Frith AE, Hernandez-Aya LF, Poplack SS (2021). Early Assessment Window for Predicting Breast Cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography. Breast Cancer Res Treat, 188(3), 615-630.
  3. Binneboese A, Covington MF, Horn KP, Archibald ZG, Boucher KM, Morton KA, Hoffman JM (2021). Correlation between FDG-PET uptake and survival in patients with primary brain tumors. Am J Nucl Med Mol Imaging, 11(3), 196-206.
  4. Covington MF (2020). Contrast-Enhanced Mammography Implementation, Performance, and Use for Supplemental Breast Cancer Screening. Radiol Clin North Am, 59(1), 113-128.
  5. Lundeen TF, Covington M, Krupinski EA, Avery R, Lei H, Sherman SJ, Kuo PH (2019). Accuracy of Dopamine Transporter Imaging with 123I-Ioflupane in Hispanic and Non-Hispanic Patients. J Nucl Med Technol, 48(2), 154-157.
  6. Brown M, Covington MF (2019). Comparative benefit to risk of molecular breast imaging, 2D full-field digital mammography with and without tomosynthesis, and synthetic mammography with tomosynthesis.
  7. Yang M, Covington MF, Nguyen BD, Johnson GB, Mesa RA, Roarke MC (2018). 99mTc-Sulfur Colloid Bone Marrow Scintigraphy in Diagnosis of Diffuse Pulmonary Extramedullary Hematopoiesis Secondary to Myelofibrosis. J Nucl Med Technol, 46(4), 368-372.
  8. Lundeen TF, Seibyl JP, Covington MF, Eshghi N, Kuo PH (2018). Signs and Artifacts in Amyloid PET. Radiographics, 38(7), 2123-2133.
  9. Hilal T, Covington M, Kosiorek HE, Zwart C, Ocal IT, Pockaj BA, Northfelt DW, Patel BK (2018). Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy. Breast J, 24(6), 1010-1014.
  10. Patel BK, Covington M, Pizzitola VJ, Lorans R, Giurescu M, Eversman W, Lewin J (2018). Initial Experience of Tomosynthesis-Guided Vacuum-Assisted Biopsies of Tomosynthesis-Detected (2D Mammography and Ultrasound Occult) Architectural Distortions. AJR Am J Roentgenol, 210(6), 1395-1400.
  11. Patel BK, Hilal T, Covington M, Zhang N, Kosiorek HE, Lobbes M, Northfelt DW, Pockaj (2018). Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy. . Ann Surg Oncol, 25(5), 1350-1356.
  12. Covington MF, Choudhary G, Jedd, AS, Sharma P, Nael K, Krupinski EA, Khan R (2017). Feasibility study of flow compensation to improve diagnostic quality of T1 post contrast spin echo MRI through the posterior fossa. Int J Health Sci, 5, 31-5.
  13. Covington MF (2016). A Graduate's Perspective on the ABR Dual Certification Pathway in Nuclear Radiology and Diagnostic Radiology. J Am Coll Radiol, 13(11), 1369-1370.
  14. Covington MF, Choudhary G, Avery RJ, Krupinski EA, Kuo PH (2016). Optimal Time Points for Scintigraphic Imaging of Pleuroperitoneal Shunts. Clin Nucl Med, 41(10), 766-8.
  15. Covington MF, McMillan NA, Kuo PH (2016). Impact of Reimbursement Cuts on the Sustainability and Accessibility of Dopamine Transporter Imaging. J Am Coll Radiol, 13(9), 1039-43.
  16. Petkovska I, Martin DR, Covington MF, Urbina S, Duke E, Daye ZJ, Stolz LA, Keim SM, Costello JR, Chundru S, Arif-Tiwari H, Gilbertson-Dahdal D, Gries L, Kalb B (2016). Accuracy of Unenhanced MR Imaging in the Detection of Acute Appendicitis: Single-Institution Clinical Performance Review. Radiology, 279(2), 451-60.
  17. Covington MF, Sherman S, Lewis D, Lei H, Krupinski E, Kuo PH (2015).  Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging. . PLoS One, 10(7), e0134457.
  18. Covington MF (2015). ACR: What every radiology resident should know (and do). J Am Coll Radiol, 13, 109-10.
  19. Covington MF, Krupinski E, Avery RJ, Kuo PH (2014). Classification schema of symptomatic enterogastric reflux utilizing sincalide augmentation on hepatobiliary scintigraphy. . J Nucl Med Technol, 42(3), 198-202.
  20. Covington MF, McMillan NA, Avery RJ, Kuo PH (2013).  The semicolon sign: dopamine transporter imaging artifact from head tilt. . J Nucl Med Technol, 41(2), 105-7.
  21. Covington MF, Agan DL, Liu Y, Johnson JO, Shaw DJ (2013). Teaching cost-conscious medicine: impact of a simple educational intervention on appropriate abdominal imaging at a community-based teaching hospital. J Grad Med Educ, 5(2), 284-8.

Review

  1. Covington MF, Pizzitola VJ, Lorans R, Pockaj BA, Northfelt DW, Appleton CM, Patel BK (2018). The Future of Contrast-Enhanced Mammography. [Review]. AJR Am J Roentgenol, 210(2), 292-300.
  2. Covington MF, Chin SS, Osborn AG (2011). Pituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893. . [Review]. AJNR Am J Neuroradiol, 32(11), 2067-72.

Book Chapter

  1. Covington MF (2020). Contrast-enhanced mammography implementation, performance, and use for supplemental breast cancer screening. . In In Freer P (Ed.), Magnetic Resonance Imaging Clinics of North America (59, pp. 113-128). Amsterdam: Elsevier.
  2. Covington MF, Young CA, Appleton CM (2018). American College of Radiology Performance Metrics, Reimbursement, and Economic Considerations in Breast MR Imaging. In Leung JWT (Ed.), Current MR Imaging of Breast Cancer, Magnetic Resonance Imaging Clinics of North America (26, pp. 303-14). Amsterdam: Elsevier.
  3. Covington MF, Schwarz S, Hoffman JM (). The Regulatory and Reimbursement Process for Imaging Agents and Devices. . In In Ross and Gambhir (Eds.), Molecular Imaging: Principles and Practice (2). Amsterdam: Elsevier.

Case Report

  1. Pandika V, Covington MF (2019). Incidental uptake in benign gynecomastia on 68Ga-DOTATATE PET/CT. Clin Nucl Med, 44(10), 799-800.
  2. Pandika V, Covington MF (2019). FDG PET/CT and ultrasound evaluation of breast implant-associated anaplastic large cell lymphoma. Clin Nucl Med, 45(1), 68-73.
  3. Covington MF, Curiel CN, Lattimore L, Avery RJ, Kuo PH (2017). FDG-PET/CT for Monitoring Response of Melanoma to the Novel Oncolytic Viral Therapy Talimogene Laherparepvec. Clin Nucl Med, 42(2), 114-115.

Editorial

  1. Covington MF (2020). Impact of time awake and hours slept at night on radiologists’ mammogram interpretations: why we must not burnout on radiologist burnout. . 18(5), 739-740.

Letter

  1. Zenger SK, Covington MF (2021). Comparison of Country of Origin, Research Collaborations, and Funding for Original Scientific Publications in the Journal Radiology from 2009 and 2019. [Letter to the editor]. Radiology, 299(1), E221-E222.
  2. Covington MF (2020). Molecular breast imaging deserves fair and balanced consideration.  [Letter to the editor]. 2(6), 519.
  3. Covington MF, Brown M (2020). Molecular Breast Imaging at Ultra-Low Radiation Dose. [Letter to the editor]. AJR Am J Roentgenol, 215(2), W30.
  4. Covington MF (2019). Molecular Breast Imaging Under Threat by the Protecting Access to Medicare Act and ACR Appropriate Use Criteria. [Letter to the editor]. J Am Coll Radiol, 17(4), 445.

Huntsman Cancer Institute News

Letter of Hope from Matt Covington, MD, from the Center for Quantitative Cancer Imaging

Six New Cancer Research Fellows Announced by 5 For The Fight

Department News

New Faculty: Matthew Covington, MD, and Prasanth Prasanna, MD

Site Links

  • Find an Interpreter
  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • Referring Providers

Helpful Links

  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Surprise Billing Rights
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube
  • Instagram

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2022 University of Utah Health